Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The C-terminal parathyroid hormone receptor (CPTHR) is a specialized receptor that specifically binds to the carboxyl-terminal fragments of parathyroid hormone (PTH), such as PTH(53-84) and PTH(39-84) (Divieti et al., 2001). While the well-characterized PTH1 receptor (PTH1R) mediates the classical calcemic actions of PTH via its N-terminal domain, the CPTHR appears to mediate distinct and often opposing biological effects, particularly in bone metabolism (Slatopolsky et al., 2000). It is predominantly expressed in osteoblasts and osteocytes, where it is thought to inhibit bone resorption and promote osteocyte survival (D'Amour, 2012). In clinical contexts, particularly chronic kidney disease (CKD), C-terminal PTH fragments accumulate significantly due to reduced renal clearance, potentially leading to skeletal resistance to PTH by competing for binding or exerting inhibitory effects through the CPTHR (Murray et al., 2005). Although the molecular identity of the CPTHR has been a subject of ongoing research and it has not been cloned as a unique gene, it is functionally classified as a G protein-coupled receptor (Bringhurst, 2002). Understanding this receptor is crucial for managing renal osteodystrophy and developing more precise therapies for metabolic bone diseases.
Agonism of the CPTHR by C-terminal fragments of PTH, which modulates bone turnover and osteocyte activity, often opposing the actions of the PTH1 receptor (Slatopolsky et al., 2000; D'Amour, 2012).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-terminal parathyroid hormone receptor (CPTHR) (CPTHR).